Amanda J. Leach
Elite in Otitis

Amanda J. Leach

John Mathews Building 58, Rocklands Dr, 
Tiwi, NT, AU 
Elite in Otitis
John Mathews Building 58, Rocklands Dr, 
Tiwi, NT, AU 
OverviewLocationsClinical Research

Overview

Amanda Leach practices in Tiwi, Australia. Ms. Leach is rated as an Elite expert by MediFind in the treatment of Otitis. Her top areas of expertise are Otitis, Strep Throat, Otitis Media with Effusion, Hearing Loss, and Myringotomy.

Her clinical research consists of co-authoring 95 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 43 articles and participated in 3 clinical trials in the study of Otitis.

Gender
Female

Locations

John Mathews Building 58, Rocklands Dr, Tiwi, NT 0810, Australia
Other Locations
Building 58, Rocklands Drive, Darwin, NT 0810, Australia
Rocklands Drive, Tiwi, NT, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Hearing for Learning Initiative - a Service-enhancement Model of Ear Health Facilitators to Address the Crisis in Ear and Hearing Health of Aboriginal Children in the Northern Territory: a Stepped-wedge Cluster Randomised Trial
The Hearing for Learning Initiative - a Service-enhancement Model of Ear Health Facilitators to Address the Crisis in Ear and Hearing Health of Aboriginal Children in the Northern Territory: a Stepped-wedge Cluster Randomised Trial
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomised Controlled Trial of Pneumococcal Conjugate Vaccines Synflorix and Prevenar13 in Sequence or Alone in High-risk Indigenous Infants (PREV-IX_COMBO): Immunogenicity, Carriage and Otitis Media Outcomes
A Randomised Controlled Trial of Pneumococcal Conjugate Vaccines Synflorix and Prevenar13 in Sequence or Alone in High-risk Indigenous Infants (PREV-IX_COMBO): Immunogenicity, Carriage and Otitis Media Outcomes
Enrollment Status: Completed
Publish Date: October 18, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

95 Total Publications

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
Journal: PLoS medicine
Published: March 06, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Leach's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile